IART · Nasdaq · CIK 0000917520

INTEGRA LIFESCIENCES HOLDINGS CORP

INTEGRA LIFESCIENCES HOLDINGS CORP’s most recent SEC filing in our snapshot is a Form 10-Q filed on Oct 23, 2026. In fiscal 2025 (year ended Dec 31, 2025) it reported revenue of $1.6B and net income of -$516.5M, according to its XBRL data on EDGAR. Its EDGAR record lists 24 Form 4 insider filings from the 12 months before our last refresh.

SEC EDGAR snapshot updated Oct 27, 2026, 11:27 PM EDT. See all filings on sec.gov.

Revenue, FY2025
$1.6B
Net income, FY2025
-$516.5M
Form 4 filings on record, past 12 months
24

Company overview

Legal name (as filed)
INTEGRA LIFESCIENCES HOLDINGS CORP
Ticker
IART
SEC Central Index Key (CIK)
0000917520
Business address
PRINCETON, NJ
State or country of incorporation
DE
Fiscal year ends
December 31
SEC filer category
Large accelerated filer
Position in SEC ticker list
#2464 of the 3,000 companies we track

Five-year financial highlights

Full-year figures from INTEGRA LIFESCIENCES HOLDINGS CORP’s annual reports, as tagged in XBRL and published by the SEC. Amounts are in U.S. dollars; the fiscal year is named for the calendar year in which it ends.

Revenue
$1.5BFY2021$1.6BFY2022$1.5BFY2023$1.6BFY2024$1.6BFY2025
Net income
$169.1MFY2021$180.6MFY2022$67.7MFY2023-$6.9MFY2024-$516.5MFY2025
IART annual results
ItemFY2021
ended Dec 31, 2021
FY2022
ended Dec 31, 2022
FY2023
ended Dec 31, 2023
FY2024
ended Dec 31, 2024
FY2025
ended Dec 31, 2025
Revenue$1.5B$1.6B$1.5B$1.6B$1.6B
Net income$169.1M$180.6M$67.7M-$6.9M-$516.5M
Diluted EPS$1.98$2.16$0.84-$0.09-$6.74
Total assets$3.8B$3.9B$3.8B$4.0B$3.6B
Cash and equivalents$513.4M$456.7M$276.4M$246.4M$235.0M

XBRL tags used: revenue = RevenueFromContractWithCustomerExcludingAssessedTax; netIncome = NetIncomeLoss; assets = Assets; eps = EarningsPerShareDiluted; cash = CashAndCashEquivalentsAtCarryingValue. EPS is shown as originally reported for each year and may not be adjusted for later stock splits. A dash means the company did not report that item in a form we could match.

How to read these numbers

Revenue is the money a company brings in from selling its products and services; net income is what is left after all expenses, interest and taxes. Diluted EPS spreads net income across every share that could exist if options and convertible securities were exercised. Total assets and cash are balance-sheet figures measured on the last day of the fiscal year. For the full story — segment results, one-time charges, guidance — read Management’s Discussion and Analysis in the Form 10-K.

Latest key reports

The most recent filing of each major report type, even if it falls outside the 40 newest filings below.

IART latest annual, quarterly, current and proxy reports
FiledFormWhat it isOriginal
Feb 26, 202610-KAnnual report· period Dec 31, 2025Document · Index
Oct 23, 202610-QQuarterly report· period Sep 30, 2026Document · Index
Oct 21, 20268-KResults of operations· period Oct 21, 2026Document · Index
Apr 6, 2026DEF 14ADefinitive proxy statement· period Dec 31, 2025Document · Index

Recent SEC filings

The 40 newest documents filed by or about INTEGRA LIFESCIENCES HOLDINGS CORP, by form type:

4 ×178-K ×1010-Q ×33 ×2SCHEDULE 13G/A ×2SCHEDULE 13G ×2SD ×1S-8 ×1DEFA14A ×1DEF 14A ×1
IART recent filings
FiledFormWhat it isOriginal
Oct 23, 202610-QQuarterly report· period Sep 30, 2026Document · Index
Oct 21, 20268-KResults of operations· period Oct 21, 2026Document · Index
Oct 19, 20268-KMaterial agreement; Agreement terminated; New financial obligation; Regulation FD disclosure· period Oct 19, 2026Document · Index
Oct 13, 20263Initial statement of beneficial ownership· period Oct 1, 2026Document · Index
Oct 9, 20268-KRegulation FD disclosure· period Oct 9, 2026Document · Index
Oct 2, 20268-KResults of operations; Regulation FD disclosure· period Oct 2, 2026Document · Index
Sep 28, 20263Initial statement of beneficial ownership· period Sep 17, 2026Document · Index
Sep 8, 20268-KRegulation FD disclosure· period Sep 8, 2026Document · Index
Sep 4, 20264Statement of changes in beneficial ownership (insider trade)· period Sep 1, 2026Document · Index
Aug 13, 2026SCHEDULE 13G/APassive beneficial ownership report (over 5%)Document · Index
Jul 31, 2026SCHEDULE 13GPassive beneficial ownership report (over 5%)Document · Index
Jul 29, 202610-QQuarterly report· period Jun 30, 2026Document · Index
Jul 29, 20268-KResults of operations· period Jul 29, 2026Document · Index
Jul 6, 20264Statement of changes in beneficial ownership (insider trade)· period Jul 3, 2026Document · Index
Jul 6, 20264Statement of changes in beneficial ownership (insider trade)· period Jul 1, 2026Document · Index
Jul 6, 20264Statement of changes in beneficial ownership (insider trade)· period Jul 1, 2026Document · Index
Jul 6, 20264Statement of changes in beneficial ownership (insider trade)· period Jul 1, 2026Document · Index
Jun 3, 20264Statement of changes in beneficial ownership (insider trade)· period Jun 1, 2026Document · Index
Jun 3, 20264Statement of changes in beneficial ownership (insider trade)· period Jun 1, 2026Document · Index
May 29, 2026SDSpecialized disclosure report (conflict minerals)Document · Index
May 15, 2026SCHEDULE 13GPassive beneficial ownership report (over 5%)Document · Index
May 11, 20264Statement of changes in beneficial ownership (insider trade)· period May 7, 2026Document · Index
May 11, 20264Statement of changes in beneficial ownership (insider trade)· period May 7, 2026Document · Index
May 11, 20264Statement of changes in beneficial ownership (insider trade)· period May 7, 2026Document · Index
May 11, 20264Statement of changes in beneficial ownership (insider trade)· period May 7, 2026Document · Index
May 11, 20264Statement of changes in beneficial ownership (insider trade)· period May 7, 2026Document · Index
May 11, 20264Statement of changes in beneficial ownership (insider trade)· period May 7, 2026Document · Index
May 8, 2026S-8Registration of employee benefit plan securitiesDocument · Index
May 8, 20268-KDirector or officer change; Shareholder vote results· period May 7, 2026Document · Index
May 5, 202610-QQuarterly report· period Mar 31, 2026Document · Index
May 5, 2026DEFA14AAdditional proxy soliciting materialsDocument · Index
May 5, 20268-KDirector or officer change· period Apr 30, 2026Document · Index
May 5, 20268-KResults of operations· period May 5, 2026Document · Index
Apr 15, 20268-KMaterial agreement· period Apr 10, 2026Document · Index
Apr 6, 2026DEF 14ADefinitive proxy statement· period Dec 31, 2025Document · Index
Mar 27, 2026SCHEDULE 13G/APassive beneficial ownership report (over 5%)Document · Index
Mar 12, 20264Statement of changes in beneficial ownership (insider trade)· period Mar 11, 2026Document · Index
Mar 12, 20264Statement of changes in beneficial ownership (insider trade)· period Mar 11, 2026Document · Index
Mar 12, 20264Statement of changes in beneficial ownership (insider trade)· period Mar 10, 2026Document · Index
Mar 12, 20264Statement of changes in beneficial ownership (insider trade)· period Mar 10, 2026Document · Index

Insider filing activity

24 Form 4 filings appear in INTEGRA LIFESCIENCES HOLDINGS CORP’s EDGAR record between Oct 28, 2025 and our last refresh. Most are reports by the company’s own directors, officers and 10% owners, but EDGAR also lists a Form 4 under a company when the company itself is the insider — for example, when it owns more than 10% of another public company. Foreign private issuers’ own insiders generally do not file Form 4. A high count is not by itself a signal: many Form 4s report routine stock awards, tax withholding or sales under pre-arranged Rule 10b5-1 plans. Open each filing to see the transaction code, share count and price. What a Form 4 shows.

Other companies in Surgical & Medical Instruments & Apparatus

All 51 companies in Surgical & Medical Instruments & Apparatus· Companies headquartered in New Jersey

On Amazon

Popular tools for investors

As an Amazon Associate I earn from qualifying purchases.

Source

  • U.S. Securities and Exchange Commission, EDGAR submissions for CIK 0000917520 and XBRL company facts. INTEGRA LIFESCIENCES HOLDINGS CORP on EDGAR.
  • Snapshot updated Oct 27, 2026, 11:27 PM EDT. The SEC does not endorse OpenFilings. Company names and tickers are used only to identify the filer; no logos are shown.

Not investment advice. This page summarizes public SEC filings for information only. Figures may contain errors or omissions; confirm everything in the original filing before relying on it.